Global Albumin Market Growth 2025-2031

Global Albumin Market Growth 2025-2031

The global Albumin market size is predicted to grow from US$ 6004 million in 2025 to US$ 9202 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

Global albumin control main manufactuers include CSL, Grifols, Takeda, Octapharma, etc., totally accounting for about 58% of the market. Asia Pacific is the largest production market, with a share over 45%.

As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 77%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 64%.

LP Information, Inc. (LPI) ' newest research report, the “Albumin Industry Forecast” looks at past sales and reviews total world Albumin sales in 2024, providing a comprehensive analysis by region and market sector of projected Albumin sales for 2025 through 2031. With Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Albumin industry.

This Insight Report provides a comprehensive analysis of the global Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Albumin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Albumin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Albumin.

This report presents a comprehensive overview, market shares, and growth opportunities of Albumin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin

Segmentation by Application:
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Thermo Fisher
Merck
Cytiva
Proliant Biologicals
Sartorius

Key Questions Addressed in this Report

What is the 10-year outlook for the global Albumin market?

What factors are driving Albumin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Albumin market opportunities vary by end market size?

How does Albumin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.